![]() |
|
|
Vol. 292, Issue 2, 672-683, February 2000
Institut de Recherches Servier, Centre de Recherches de Croissy,
Psychopharmacology Department, Croissy-sur-Seine, Paris, France.
We examined the involvement of multiple monoaminergic receptors in the
induction of spontaneous tail-flicks (STFs) by the open channel blocker
at N-methyl-D-aspartate (NMDA) receptors, dizocilpine, and the NMDA recognition site antagonist
3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP). At
doses eliciting a maximal STF response, dizocilpine and CPP elevated
levels of norepinephrine, but not dopamine or serotonin, in
dialysates of nucleus accumbens, their known locus of action in
eliciting STFs. Chemically diverse
2-adrenergic receptor
(AR) antagonists atipamezole, L745,743, RX821,002, idazoxan, and
desfluparoxan abolished induction of STFs by dizocilpine, whereas the
preferential
1-AR antagonists prazosin, WB4101, and ARC239 were weakly active: relative potencies in blocking STFs correlated significantly with affinity at
2-ARs.
The D1/D5 receptor antagonists SCH23390,
SCH39166, and NNC756 potently abolished STFs, whereas the
D2 antagonist L741,626, the D3 antagonists
GR218,231 and S14297, and the D4 antagonists S18126 and
L745,870 were inactive. D1 and
2-AR
antagonists also blocked induction of STFs by CPP. Blockade of
dizocilpine-induced STFs was specific inasmuch as idazoxan and SCH
23390 did not modify induction of ataxia by dizocilpine. Antagonists at
multiple 5-hydroxytryptamine receptors failed to modify induction of
STFs. Finally, dizocilpine-induced STFs were blocked by clozapine and
11 other antipsychotics, the potency of which correlated significantly
with affinity at
2-ARs. In conclusion, STFs evoked by
interruption of transmission at NMDA receptors are dependent on
D1 receptors and
2-ARs for their expression. Antagonism of the
2-ARs is involved in their blockade by
antipsychotics. This model should facilitate exploration of
interrelationships between glutamatergic and monoaminergic mechanisms
involved in psychiatric and neurologic disorders.